Stevens-Johnson Syndrome without Skin Lesions: A Rare and Clinically Challenging Disease in the Urgent Setting

Authors

  • Ursula M. Anders Research Department, Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cor- dova, 95670 CA, USA
  • Elise J. Taylor Research Department, Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cor- dova, 95670 CA, USA
  • Victoria Kravchuk Research Department, Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cor- dova, 95670 CA, USA
  • Joseph R. Martel Research Department, Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cor- dova, 95670 CA, USA; Graduate Medical Education, California Northstate University College of Medicine, 9700 West Taron Drive, Elk Grove, 95757 CA, USA; Department of Ophthalmology, Dignity Health, 6501 Coyle Avenue, Carmichael, 95608 CA USA
  • James B. Martel Research Department, Martel Eye Medical Group, 11216 Trinity River Drive, Rancho Cor- dova, 95670 CA, USA; Graduate Medical Education, California Northstate University College of Medicine, 9700 West Taron Drive, Elk Grove, 95757 CA, USA; Department of Ophthalmology, Dignity Health, 6501 Coyle Avenue, Carmichael, 95608 CA USA

DOI:

https://doi.org/10.17140/EMOJ-1-106

Keywords:

Stevens-Johnson syndrome, Toxic epidermal necrolysis, Erythema multiforme, Immunohistochemical, Episcleritis, Ulcerative stomatitis, Mycoplasma pneumoniae associated mucositis (MPAM), Fuchs syndrome, Major histocompatibility class, Non-MPAM atypical Stevens-Johnson syndrome

Abstract

Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme are life threatening diseases causing mucocutaneous eruptions and can be difficult to manage medically. When oral tissues are involved, airway management can be of critical importance. Fluid and electrolyte imbalance are common and protocols to prevent secondary infection are initiated. All three conditions are rapidly evolving. Stevens-Johnson syndrome is more commonly associated with Mycoplasma pneumoniae in the pediatric population and drug hypersensitivity in adults, whereas erythema multiforme is mostly associated with herpes simplex virus in the adult population. These diseases are T-cell-mediated immune reactions, thought to represent a spectrum of the same disease. Clinical and immunohistochemical techniques are capable of differentiating Stevens-Johnson syndrome from erythema multiforme and provide insight into the possible underlying pathology creating the disease. Rare cases of Stevens-Johnson syndrome without skin manifestations have been associated with Mycoplasma pneumoniae and predominantly occur in males. In-hospital management is recommended to provide airway support, maintain fluid intake, electrolyte balance, obtain multi-speciality consultation, and to perform diagnostic testing. We describe a case of a 14 year old male with atypical Stevens-Johnson syndrome and a review of the literature.

References

Iwai S, Sueki H, Watanabe H, Sasaki Y, Suzuki T, Iijima M. Distinguishing Between erythema multiforme major and Ste-vens-Johnson syndrome/toxic epidermal necrolysis j. J Dermatol. 2012; 39(9): 781-786. doi: 10.1111/j.1346-8138.2012.01532.x

Wetter DA, Davis MD. Recurrent erythema multiforme: clini-cal characteristics, etiologic associations, and treatment in a se-ries of 48 patients at mayo clinic, 2000 to 2007. J Am Acad Der-matol. 2010; 62(1): 45-53. doi: 10.1016/j.jaad.2009.06.046

Mockenhaupt M. The current understanding of Stevens-John-son syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011; 7(6): 803-813. doi: 10.1586/eci.11.66

Latsch K, Girschick HJ, Abele-Horn, M. Stevens-Johnson syndrome without skin lesions: case report. J Med Microbiol. 2007; 56(Pt 12): 1696-1699. doi: 10.1099/jmm.0.47318-0

Alter SJ, Stringer B. Mycoplasma pneumoniae infections as-sociated with severe mucositis. Clin Pediatr. 1990; 29(10): 602- 604.

Bressan S, Mion T, Andreola B, Bisogno G, Da Dalt L. Severe mycoplasma pneumoniae-associated mucositis treated with im-munoglobulins. Acta Paediatr. 2011; 100(11): e238-e240. doi: 10.1111/j.1651-2227.2011.02342.x

Fearon D, Hesketh EL, Mitchell AE, Grimwood K. Myco-plasma pneumoniae infection complicated by pneumomediasti-num and severe mucositis. J Paediatr Child Health. 2007; 43(5): 403-405. doi: 10.1111/j.1440-1754.2007.01088.x

Lamireau T, Leaute-Labreze C, Le Bail B, Taieb A. Esopha-geal involvement in Stevens-Johnson syndrome. Endoscopy. 2001; 33(6): 550-553. doi: 10.1046/j.1525-1470.2003.03012.x

Meyer Sauteur PM, Goetschel P, Lautenschlager S. Myco-plasma pneumoniae and mucositis-part of the Stevens-Johnson syndrome spectrum. J Dtsch Dermatol Ges. 2012; 10(10): 740- 746. doi: 10.1111/j.1610-0387.2012.07951.x

Ravin KA, Rappaport LD, Zuckerbraun NS, Wadowsky RM, Wald ER, Michaels MM. Mycoplasma pneumoniae and atypi-cal Stevens-Johnson syndrome: a case series. Pediatrics. 2007; 119(4): e-1002-e1005. doi: 10.1542/peds.2006-2401

Schalock PC, Dinulos JG. Mycoplasma pneumoniae-Induced Stevens-Johnson Syndrome without skin lesions: fact or fiction? J Am Acad Dermatol. 2005; 52(2): 312-315. doi: 10.1016/j. jaad.2004.07.044

Strawn JR, Whitsel R, Nandagopal JJ, Delbello MP. Atypi-cal Stevens-Johnson syndrome in an adolescent treated with du-loxetine. J Child Adolesc Psychopharmacol. 2011; 21(1): 91-92. doi: 10.1089/cap.2010.0071

Trapp LW, Schrantz SJ, Joseph-Griffin MA, Hageman JR, Waskow SE. A 13-year-old boy with pharyngitis, oral ulcers, and dehydration. mycoplasma pneumoniae-associated mucosi-tis. Pediatr Ann. 2013; 42(4): 148-150. doi: 10.3928/00904481- 20130326-06

Vanfleteren I, Gysel DV, De Brandt C. Stevens-Johnson syn-drome: a diagnostic challenge in the absence of skin lesions. Pe-diat Dermatol. 2003; 20(1): 52-56.

Birch J, Chamlin S, Duerst R, Jacobsohn D. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a he-matopoietic stem cell transplant recipient. Pediatr Blood Can-cer. 2008; 50(6): 1278-1279. doi: 10.1002/pbc.21493

Havliza K, Jakob A, Rompel R. Erythema multiforme majus (fuchs syndrome) associated with mycoplasma pneumoniae in-fection in two patients. J Dtsch Dermatol Ges. 2009; 7(5): 445- 448. doi: 10.1111/j.1610-0387.2008.06978.x

Hillebrand-Haverkort ME, Budding AE, bij de Vaate LA, van Agtmael MA. Mycoplasma pneumoniae infection with in-complete Stevens-Johnson syndrome. Lancet Infect Dis. 2008; 8(10): 586-587. doi: 10.1016/S1473-3099(08)70209-3

Kirke S, Powell FC. Mucosal erosions and a cough. Ir Med J. 2003; 96(8): 245.

Li K, Haber RM. Stevens-Johnson syndrome without skin lesions (fuchs syndrome): a literature review of adult cases with mycoplasma cause. Arch Dermatol. 2012; 148(8): 963-964. doi: 10.1001/archdermatol.2012.681

Majima Y, Ikeda Y, Yagi H, Enokida K, Miura T, Tokura Y. Colonic involvement in Stevens-Johnson syndrome-like mu-cositis without skin lesions. Allergol Int. 2015; 64(1): 106-108. doi: 10.1016/j.alit.2014.08.010

McGouran DC, Petterson T, McLaren JM, Wolbinski MP. Mucositis, conjunctivitis but no rash- the atypical Stevens-John-son syndrome. Acute Med. 2011; 10(2): 81-82.

Ramasamy A, Patel C, Conlon C. Incomplete Stevens-John-son syndrome secondary to atypical pneumonia. BMJ Case Rep. 2011; 2011. doi: 10.1136/bcr.08.2011.4568

Sieber Of Jr, John TJ, Fulginiti VA, Overholt EC. Stevens-Johnson syndrome associated with mycoplasma pneumoniae in-fection. JAMA. 1967; 200(1): 79-81.

Sternbersky J, Tichy M. Fuchs’ syndrome (Stevens-Johnson syndrome without skin involvement) in an adult male - a case report and general characteristics of the sporadically diagnosed disease. Acta Dermatovenerol Croat. 2014; 22(4): 284-287.

Varghese C, Sharain K, Skalski J, Ramar K. Mycoplasma pneumonia-associated mucositis. BMJ Case Rep. 2014; 2014.

Vujic I, Shroff A, Grzelka M, et al. Mycoplasma pneumoni-ae-associated mucositis - case report and systematic review of literature. J Eur Acad Dermatol Venerol. 2014; 1-4.

Walicka M, Majsterek M, Rakowska A, et al. Mycoplasma pneumoniae‐induced pneumonia with Stevens‐Johnson syn-drome of acute atypical course. Pol Arch Med Wewn. 2008; 118(7-8): 449-453.

Yachoui R, Kolasinski S, Feinstein, D. Mycoplasma pneu-moniae with atypical Stevens-Johnson syndrome: a diagnos-tic challenge. Case Rep Infect Dis. 2013; 2013: 457161. doi: 10.1155/2013/457161

Bascones-Martínez A, García-García V, Meurman JH, Re-quena-Caballero L. Immune-mediated diseases: what can be found in the oral cavity? Int J Dermatol. 2014. doi: 10.1111/ ijd.12681

Schneider G, Kachroo S, Jones N, et al. A systematic review of validated methods for identifying erythema multiforme ma-jor/minor/not otherwise specified, Stevens-Johnson syndrome, or toxic epidermal necrolysis using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 1): 236- 239. doi: 10.1002/pds.2331

Scully C, Bagan J. Oral mucosal diseases: erythema mul-tiforme. Br J Oral Maxillofac Surg. 2008; 46(2): 90-95. doi: 10.1016/j.bjoms.2007.07.202

Stevens AM, Johnson, FC. A new eruptive fever associ-ated with stomatitis and ophthalmia report of two cases in children. Am J Dis Child. 1922; 24(6): 526-533. doi: 10.1001/ archpedi.1922.04120120077005

Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose systemic steroids in the acute care of patients with Sevens-Johnson syndrome. Int Ophthalmol Clin. 2005; 45(4): 25-48.

Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol. 1996; 35(5 Pt 1): 757-760. doi: 10.1016/S0190-9622(96)90732-X

Finkelstein Y, Soon GS, Acuna P, et al. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics. 2011; 128(4): 723-728. doi: 10.1542/peds.2010-3322

Aihara Y, Ito S, Kobayashi Y, Aihara M. Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy. 2004; 59(1): 118. doi: 10.1046/j.1398-9995.2003.00336.x

Brkljacic N, Gracin S, Prkacin I, et al. Stevens-Johnson syn-drome as an unusual adverse effect of azithromycin. Acta Der-matovenerol Croat. 2006; 14(1): 40-45.

Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E. Fever, Rash and systemic symptoms: understanding the role of virus and hla in severe cutaneous drug allergy. J Allergy Clin Immunol Pract. 2014; 2(1): 21-33. doi: 10.1016/j.jaip.2013.11.005

Ueta M, Kaniwa N, Sotozona C, et al. Independent strong association of HLA-A*02:06 and HLA-B 44:03 with cold med-icine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci Rep. 2014; 4: 4862. doi: 10.1038/srep04862

Shi YW, Min FL, Qin B, et al. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in south-ern han chinese: genetic markers besides B*1502? Basic Clin Pharmacol Toxicol. 2012; 111(1): 58-64. doi: 10.1111/j.1742- 7843.2012.00868.x

Cheng CY, Su SC, Chen CH, Chen WL, Deng ST, Chung WH. HLA Associations and clinical implications in T-cell-me-diated drug hypersensitivity reactions: an updated review. J Im-munol Res. 2014; 2014: 565320. doi: 10.1155/2014/565320

Power WJ, Saidman SL, Zhang DS, et al. HLA typing in pa-tients with ocular manifestations of Stevens-Johnson syndrome. Ophthalmology. 1996; 103(9): 1406-1409.

Daubeney PE, Scopes JW. Recurrent Stevens-Johnson syn-drome. J R Soc Med. 1991; 84(3): 168.

Su SC, Chung WH. Cytotoxic proteins and therapeutic tar-gets in severe cutaneous adverse reactions. Toxins. 2014; 6(1): 194-210. doi: 10.3390/toxins6010194

Atkinson TP, Boppana S, Theos A, Clements LS, Xiao L, Waites K. Stevens-Johnson syndrome in a boy with macrolide-resistant mycoplasma pneumoniae pneumonia. Pediatrics. 2011; 127(6): e1605-e1609. doi: 10.1542/peds.2010-2624

Downloads

Published

2015-05-22

How to Cite

Ursula M. Anders, Elise J. Taylor, Victoria Kravchuk, Joseph R. Martel, & James B. Martel. (2015). Stevens-Johnson Syndrome without Skin Lesions: A Rare and Clinically Challenging Disease in the Urgent Setting. Emergency Medicine, 1(2), 22–30. https://doi.org/10.17140/EMOJ-1-106